Related Experiment Video
Updated: Apr 25, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
The central role of mitochondria in axonal degeneration in multiple sclerosis
Graham R Campbell1, Joseph T Worrall1, Don J Mahad2
1Centre for Neuroregeneration, University of Edinburgh, UK.
Abstract:
Neurodegeneration in multiple sclerosis (MS) is related to inflammation and demyelination. In acute MS lesions and experimental autoimmune encephalomyelitis focal immune attacks damage axons by injuring axonal mitochondria. In progressive MS, however, axonal damage occurs in chronically demyelinated regions, myelinated regions and also at the active edge of slowly expanding chronic lesions. How axonal energy failure occurs in progressive MS is incompletely understood. Recent studies show that oligodendrocytes supply lactate to myelinated axons as a metabolic substrate for mitochondria to generate ATP, a process which will be altered upon demyelination. In addition, a number of studies have identified mitochondrial abnormalities within neuronal cell bodies in progressive MS, leading to a deficiency of mitochondrial respiratory chain complexes or enzymes. Here, we summarise the mitochondrial abnormalities evident within neurons and discuss how these grey matter mitochondrial abnormalities may increase the vulnerability of axons to degeneration in progressive MS. Although neuronal mitochondrial abnormalities will culminate in axonal degeneration, understanding the different contributions of mitochondria to the degeneration of myelinated and demyelinated axons is an important step towards identifying potential therapeutic targets for progressive MS.
Insights
Mitochondrial dysfunction in neurons contributes to axonal degeneration in multiple sclerosis (MS). Understanding these abnormalities is key to developing new therapies for progressive MS.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Neurodegeneration in multiple sclerosis (MS) is linked to inflammation and demyelination.
- In acute MS, focal immune attacks damage axonal mitochondria, while progressive MS involves axonal damage in various regions.
- The mechanisms of axonal energy failure in progressive MS remain unclear.
Purpose of the Study:
- To summarize mitochondrial abnormalities within neurons in progressive MS.
- To discuss how these grey matter mitochondrial issues increase axonal vulnerability to degeneration.
- To highlight the importance of understanding mitochondrial roles in both myelinated and demyelinated axon degeneration.
Main Methods:
- Literature review and synthesis of existing studies on mitochondrial function in MS.
- Analysis of mitochondrial abnormalities in neuronal cell bodies in progressive MS.
- Discussion of the metabolic support provided by oligodendrocytes to axons.
Main Results:
- Oligodendrocytes supply lactate to myelinated axons for mitochondrial ATP production, a process disrupted by demyelination.
- Studies reveal mitochondrial abnormalities, including deficiencies in respiratory chain complexes, within neurons in progressive MS.
- These neuronal mitochondrial defects are implicated in increasing axonal vulnerability.
Conclusions:
- Neuronal mitochondrial abnormalities are a significant factor culminating in axonal degeneration in progressive MS.
- Further research into the distinct roles of mitochondria in degenerating myelinated and demyelinated axons is crucial.
- Identifying these roles may lead to novel therapeutic targets for progressive MS.
Related Concept Videos
Mitochondria
Mitochondrial Membranes
Mitochondrial Membranes
Multiple Sclerosis l: Introduction
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

